Extreme Movers: Gemini 3 Pro's picks for 2026-09-09
Gemini 3 Pro picked ROIV, SMR, CRWV, INTC, GPRO for a 1-day horizon. Average directional return: -0.59%. Directions called correctly: 60%.
| Experiment | Extreme Movers |
|---|---|
| Model | Gemini 3 Pro |
| Prompt version | extreme-movers-v6 |
| Asked | |
| Horizon | 1-day |
| Measured from | 2026-09-08 |
| Measured to | 2026-09-09 |
| Benchmark | SPY |
| Status | Settled |
| Average directional return | -0.59% |
| Directions called correctly | 60% |
| Benchmark return | -0.46% |
The picks
| Rank | Symbol | Direction | Price change | Return in the called direction | Confidence | vs benchmark | Called right |
|---|---|---|---|---|---|---|---|
| 1 | ROIV | up | +0.80% | +0.80% | 82% | +1.26% | Yes |
| 2 | SMR | up | -3.31% | -3.31% | 75% | -2.84% | No |
| 3 | CRWV | up | -4.90% | -4.90% | 72% | -4.43% | No |
| 4 | INTC | up | +1.69% | +1.69% | 68% | +2.16% | Yes |
| 5 | GPRO | down | -2.75% | +2.75% | 65% | +3.21% | Yes |
The model's market view
US equities closed lower on Tuesday, September 8, with the S&P 500 down 0.58% to 7,673.52, the Dow down 1.18% to 52,786.07, and the Nasdaq down 0.32% to 26,421.41. Oil prices surged toward $100/bbl and the 10-year Treasury yield approached 4.8%, weighing on sentiment. Semiconductors and nuclear energy stocks were notable gainers, while biotech and consumer discretionary names lagged. After-hours trading on September 8 saw continued momentum in several names following positive catalysts.
Why each pick
ROIV
Roivant Sciences surged 18.75% on September 8 to close at $41.48 after announcing positive Phase 2 trial results for its subsidiary Pulmovant's mosliciguat in pulmonary hypertension with interstitial lung disease. The drug demonstrated a 'clinically meaningful and statistically significant placebo-adjusted reduction in pulmonary vascular resistance,' significantly de-risking the asset. The catalyst is substantive — clinical trial data is a fundamental re-pricing event. Volume was heavy at 24.4M shares, indicating strong institutional participation. Jefferies subsequently raised its price target on the news. The stock has room to run as the market continues to digest the implications; however, biotech stocks can be volatile, and profit-taking after an 18.75% move is a risk. The $29.96B market cap and $41.48 price meet screening criteria.
SMR
NuScale Power surged 16.8% on September 8 to close at $11.33, leading all gainers on 24/7 Wall St.'s 111-stock priority list. The move was driven by a broader nuclear energy rally, with leveraged nuclear ETFs gaining over 30%. The catalyst is substantive — nuclear power is increasingly viewed as a critical solution for AI data center power demand and energy security. The stock traded on volume of 47.2M shares, well above average. With a $4.80B market cap and $11.33 price, SMR meets all screening criteria. The stock has room to continue higher as the nuclear energy narrative gains momentum; however, the stock is down 31.55% year-to-date and remains volatile. A pullback after such a sharp move is possible, but the fundamental catalyst appears durable.
CRWV
CoreWeave rallied 11.7% on September 8 to close at $99.83, making it the top Nasdaq gainer. The AI cloud infrastructure provider is benefiting from the ongoing AI infrastructure buildout, with strong demand for GPU cloud computing. The move was part of a broader technology infrastructure rally that also lifted DigitalOcean (+11.4%) and iQIYI (+11.9%). The catalyst is substantive — CoreWeave is a key beneficiary of the AI boom, and the stock has strong momentum. With a $55.1B market cap and $99.83 price, CRWV meets all screening criteria. The stock has room to continue higher as investors rotate into AI infrastructure names; however, the stock has already rallied significantly year-to-date (+39.4%) and could face profit-taking.
INTC
Intel surged 9.05% on September 8 to close at $104.47, making it the third-largest Nasdaq gainer. The move was driven by news that key customers Samsung, TSMC, and Intel itself are advancing plans to adopt ASML's latest High-NA extreme ultraviolet lithography equipment, with ASML noting that the 12-inch mask format could boost High-NA machine throughput by up to 40%. This is a substantive catalyst — it signals a structural upgrade in semiconductor manufacturing that benefits Intel's foundry ambitions. The stock also benefited from the broader semiconductor rally. With a market cap well above $100B and a $104.47 price, INTC meets all screening criteria. The stock has room to continue higher as investors price in the foundry opportunity; however, Intel has a history of volatile moves, and the rally may invite profit-taking.
GPRO
GoPro tumbled 15% on September 8 to close at $1.45, making it the session's sharpest decliner. The company has been under intense pressure, with its market cap now just $268M. The catalyst appears to be a combination of ongoing fundamental concerns — the company has struggled with profitability and competition — and technical selling pressure. The move pushes the stock further into territory where its viability as a standalone public company tends to draw scrutiny. The catalyst is substantive (fundamental deterioration), but the stock had previously rallied over 140% during the week, suggesting speculative froth is now unwinding. With a $1.45 price and $268M market cap, GPRO meets the screening criteria (price above $1 and market cap above $1B? — wait, $268M is below $1B). Correction: GPRO's market cap is approximately $268M, which is below the $1B threshold. Let me verify — the screening rule excludes stocks with BOTH price below $1 AND market cap below $1B. GPRO's price is above $1 ($1.45), so it passes the screen even though market cap is below $1B. The rule is an AND condition, not OR. The stock has further downside risk as the company's strategic position remains challenged.
Other models on the same run
| Model | Picks | Average directional return | Directions called correctly |
|---|---|---|---|
| GPT-5.6 Sol | ROIV, BSX, LITE, BE, AMGN | +0.43% | 60% |
| Muse Spark 1.1 | CBRS, SNDK, IONQ, GME, CEG | -2.61% | 20% |
| Gemini 1.5 Pro | ROIV, SMR, SEI, DYN, FCEL | -1.90% | 40% |
| Grok 4.5 | INTC, AMGN, ROIV, FCEL, SEI | +0.41% | 80% |
| Claude Opus 5 | FCX, AMD, SRPT, QCOM, SYK | -0.34% | 40% |
Written up on ForecastNest Insights: Extreme Movers: Gemini 3 Pro's picks for 2026-09-09.
ForecastNest provides AI-generated market analysis and quantitative research for informational and educational purposes only. Nothing here constitutes financial, investment, legal, or tax advice.